Successful Combined Therapy with Tamoxifen and Lithium in a Paradoxical Sleep Deprivation-Induced Mania Model

CNS Neuroscience and Therapeutics

Volumn 18, Issue 2, 2012, Pages 119-125

  Armani, Fernanda ^a   Andersen, Monica L ^a   Andreatini, Roberto ^b   Frussa Filho, Roberto ^a   Tufik, Sergio ^a   Fernandes Galduróz, José Carlos ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Adjunctive therapy; Lithium; Mania; Mice; Paradoxical sleep deprivation; Protein kinase C; Tamoxifen

Indexed keywords

LITHIUM CARBONATE; PROTEIN KINASE C; TAMOXIFEN CITRATE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG RESPONSE; ENZYME INHIBITION; HYPERACTIVITY; LOCOMOTION; MALE; MANIA; MONOTHERAPY; MOUSE; NONHUMAN; OPEN FIELD BEHAVIOR; PARADOXICAL SLEEP DEPRIVATION; PSYCHOPHARMACOTHERAPY; SLEEP DEPRIVATION;

ANIMALS; ANTIMANIC AGENTS; BIPOLAR DISORDER; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; LITHIUM; MALE; MICE; MICE, INBRED C57BL; PSYCHOMOTOR AGITATION; RANDOM ALLOCATION; SLEEP DEPRIVATION; SLEEP, REM; TAMOXIFEN;

EID: 84856783706     PISSN: 17555930     EISSN: 17555949     Source Type: Journal    
DOI: 10.1111/j.1755-5949.2010.00224.x     Document Type: Article

References (49)

1. Angst J. Epidemiology of the bipolar spectrum. Encephale 1995;21:37-42.
2. Kupfer DJ. The increasing medical burden in bipolar disorder. JAMA 2005;293:2528-2530.
3. Krishnan KR. Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med 2005;67:1-8.
4. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: Re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003;73:123-131.
5. Tohen M, Zarate CA, Jr., Hennen J, et al. The McLean-Harvard First-Episode Mania Study: Prediction of recovery and first recurrence. Am J Psychiatry 2003;160:2099-2107.
6. Sachs GS, Gardner-Schuster EE. Adjunctive treatment of acute mania: A clinical overview. Acta Psychiatr Scand Suppl 2007;116:27-34.
7. Machado-Vieira R, Kapczinski F, Soares JC. Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004;28:209-224.
8. Gould TD, Einat H. Animal models of bipolar disorder and mood stabilizer efficacy: A critical need for improvement. Neurosci Biobehav Rev 2007;31:825-831.
9. Harvey AG. Sleep and circadian rhythms in bipolar disorder: Seeking synchrony, harmony, and regulation. Am J Psychiatry 2008;165:820-829.
10. Plante DT, Winkelman JW. Sleep disturbance in bipolar disorder: Therapeutic implications. Am J Psychiatry 2008;165:830-843.
11. Giglio LM, Andreazza AC, Andersen M, Cereser KM, Walz JC, Sterz L, Kapczinski F. Sleep in bipolar patients. Sleep Breath 2009;13:169-173.
12. Hudson JI, Lipinski JF, Keck PE, Jr., et al. Polysomnographic characteristics of young manic patients. Comparison with unipolar depressed patients and normal control subjects. Arch Gen Psychiatry 1992;49:378-383.
13. Wehr TA, Goodwin FK, Wirz-Justice A, Breitmaier J, Craig C. 48-hour sleep-wake cycles in manic-depressive illness: Naturalistic observations and sleep deprivation experiments. Arch Gen Psychiatry 1982;39:559-565.
14. Wehr TA, Sack DA, Rosenthal NE. Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 1987;144:201-204.
15. Wehr TA. Sleep-loss as a possible mediator of diverse causes of mania. Br J Psychiatry 1991;159:576-578.
16. Barbini B, Bertelli S, Colombo C, Smeraldi E. Sleep loss, a possible factor in augmenting manic episode. Psychiatry Res 1996;65:121-125.
17. Colombo C, Benedetti F, Barbini B, Campori E, Smeraldi E. Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression. Psychiatry Res 1999;86:267-270.
18. Gessa GL, Pani L, Fadda P, Fratta W. Sleep deprivation in the rat: An animal model of mania. Eur Neuropsychopharmacol 1995;5(Suppl):89-93.
19. Benedetti F, Fresi F, Maccioni P, Smeraldi E. Behavioural sensitization to repeated sleep deprivation in a mice model of mania. Behav Brain Res 2008;187:221-227.
20. Berns GS, Nemeroff CB. The neurobiology of bipolar disorder. Am J Med Genet C Semin Med Genet 2003;123C:76-84.
21. Ackenheil M. Neurotransmitters and signal transduction processes in bipolar affective disorders: A synopsis. J Affect Disord 2001;62:101-111.
22. Kato T. Molecular neurobiology of bipolar disorder: A disease of 'mood-stabilizing neurons'? Trends Neurosci 2008;31:495-503.
23. Wang HY, Friedman E. Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biol Psychiatry 1996;40:568-575.
24. Wang H, Friedman E. Increased association of brain protein kinase C with the receptor for activated C kinase-1 (RACK1) in bipolar affective disorder. Biol Psychiatry 2001;50:364-370.
25. Hahn CG, Umapathy, Wang HY, Koneru R, Levinson DF, Friedman E. Lithium and valproic acid treatments reduce PKC activation and receptor-G protein coupling in platelets of bipolar manic patients. J Psychiatr Res 2005;39:355-363.
26. Iwata S, Hewlett GH, Gnegy ME. Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes. Synapse 1997;26:281-291.
27. Szabo ST, Machado-Vieira R, Yuan P, et al. Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology 2009;56:47-55.
28. Wang HY, Friedman E. Lithium inhibition of protein kinase C activation-induced serotonin release. Psychopharmacology (Berl) 1989;99:213-218.
29. Manji HK, Etcheberrigaray R, Chen G, Olds JL. Lithium decreases membrane-associated protein kinase C in hippocampus: Selectivity for the alpha isozyme. J Neurochem 1993;61:2303-2310.
30. Jordan VC. A current vew of tamoxifen for the treatment of breast cancer. Br J Pharmacol 1994;110:507-510.
31. Bebchuk JM, Arfken CL, Dolan-Manji S, Murphy J, Hasanat K, Manji HK. A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 2000;57:95-97.
32. Kulkarni J, Garland KA, Scaffidi A, et al. A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology 2006;31:543-547.
33. Yildiz A, Guleryuz S, Ankerst DP, Ongur D, Renshaw PF. Protein kinase C inhibition in the treatment of mania: A double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry 2008;65:255-263.
34. Zarate CA, Jr., Singh JB, Carlson PJ, Quiroz J, Jolkovsky L, Luckenbaugh DA, Manji HK. Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: A pilot study. Bipolar Disord 2007;9:561-570.
35. Sabioni P, Baretta IP, Ninomiya EM, Gustafson L, Rodrigues AL, Andreatini R. The antimanic-like effect of tamoxifen: Behavioural comparison with other PKC-inhibiting and antiestrogenic drugs. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1927-1931.
36. Einat H, Yuan P, Szabo ST, Dogra S, Manji HK. Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: Implications for the development of novel therapeutics for bipolar disorder. Neuropsychobiology 2007;55:123-131.
37. Andersen ML, D'Almeida V, Ko GM, Kawakami R, Martins PJF, Magalhães LE, Tufik S. Procedimentos Experimentais In: UNIFESP, editor. Princípios Éticos e Práticos do uso de Animais de Experimentação. São Paulo: UNIFESP, 2004;45-69.
38. Zager A, Andersen ML, Lima MM, Reksidler AB, Machado RB, Tufik S. Modulation of sickness behavior by sleep: The role of neurochemical and neuroinflammatory pathways in mice. Eur Neuropsychopharmacol 2009;19:589-602.
39. Broadhust P. Experiments in psychogenetics. In: Eisenk, HJ, editors. Experiments in personality. London: Routledge & K Paul, 1960.
40. Calzavara MB, Andersen ML, Fukushiro DF, Lopez GB, Abilio VC, Tufik S, Frussa-Filho R. Sleep rebound attenuates context-dependent behavioural sensitization induced by amphetamine. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1277-1282.
41. Frussa-Filho R, Goncalves MT, Andersen ML, de Araujo NP, Chinen CC, Tufik S. Paradoxical sleep deprivation potentiates amphetamine-induced behavioural sensitization by increasing its conditioned component. Brain Res 2004;1003:188-193.
42. Einat H, Chen G, Manji H. Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder. Harefuah 2004;143:420-562.
43. Suchecki D, Lobo LL, Hipolide DC, Tufik S. Increased ACTH and corticosterone secretion induced by different methods of paradoxical sleep deprivation. J Sleep Res 1998;7:276-281.
44. Yildis-Yesiloglu A. Targeted treatment strategies in mania: Anti-manic effects of a PKC inhibitor tamoxifen. Biol Psychiatry 2007;61:1S-266S.
45. Schloesser RJ, Huang J, Klein PS, Manji HK. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 2007;33:110-133.
46. Zarate C, Singha J, Manji H. Cellular plasticity cascades: Targets for the development of novel therapeutics for bipolar disorder. Biol Psychiatr 2006;59:1006-1020.
47. Einat H, Manji HK. Cellular plasticity cascades: Genes-to-behavior pathways in animal models of bipolar disorder. Biol Psychiatry 2006;59:1160-1171.
48. Manji HK, Lenox RH. Signaling: Cellular insights into the pathophysiology of bipolar disorder. Biol Psychiatry 2000;48:518-530.
49. Manji H. The role of synaptic and cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Actas Esp Psiquiatr 2008;36(Suppl 1):1-2.